Keyphrases
Advanced Cancer
20%
Astrocytoma
20%
BIN3
20%
Breast Cancer Patients
20%
Cancer Patients
20%
Cerebrospinal Fluid
20%
Clinical Trials
22%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
20%
Disease Implications
20%
Distance Traveled
20%
Distant Metastasis
20%
Ependymoma
20%
Extraneural
20%
Family Caregivers
20%
Genetic Modification
25%
Glioblastoma
67%
Glioblastoma Therapy
20%
Glioma Patients
20%
Hazard Ratio
37%
Health Disparities
20%
HER2 Amplification
20%
HER2-targeted Therapy
20%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
IDH-mutant Glioma
20%
In Cancer
20%
Isocitrate Dehydrogenase mutation
20%
Leptomeningeal Disease
20%
Lung
20%
Lymph Node
20%
Malnutrition
20%
Metabolic
20%
Metastatic Disease
16%
Mutation Status
20%
Nervous System Diseases
20%
Neutrophilia
20%
Overall Survival
44%
Overall Survival of Patients
20%
Papillary Glioneuronal Tumor
20%
Pleura
20%
Poor Prognosis
22%
Post-irradiation
20%
Posttraumatic Growth
20%
Recent Advances
20%
Socioeconomic Status
20%
Standard of Care
20%
Targeted Therapy
20%
Thrombocytopenia
20%
Tumor
20%
Tumor Cells
20%
Venous Thromboembolism
20%
Medicine and Dentistry
Anorexia-Cachexia
6%
Brain Disease
6%
Breast Cancer
20%
Cancer Therapy
6%
Cancer Treatment
6%
Cerebrospinal Fluid
20%
Clinical Trial
10%
Combination Therapy
6%
Disease
47%
Disorders of Calcium Metabolism
6%
Drug Hypersensitivity
6%
Endocrine Disease
10%
Fluorescence in Situ Hybridization
6%
Functional Assessment
6%
Ganglioglioma
20%
Gene Mutation
25%
Glioblastoma
100%
Hazard Ratio
46%
Health Disparity
20%
Kaplan Meier Method
6%
Lymphocyte
20%
Malignant Neoplasm
78%
Metastatic Carcinoma
10%
Monocyte
8%
Neoplasm
46%
Nervous System Dysfunction
20%
Neutrophil
11%
Neutrophilia
20%
Nutritional Disorder
6%
Oncology
6%
Overall Survival
88%
Paraneoplastic Syndrome
20%
Peripheral Nerve
6%
Platelet
8%
Posttraumatic Growth
20%
Primary Tumor
11%
Radiation Therapy
18%
Randomized Controlled Trial
20%
Sepsis
6%
Small Cell Lung Cancer
20%
Socioeconomic Status
20%
Surgery
12%
Symptom
20%
Targeted Therapy
22%
Temozolomide
18%
Thrombocytopenia
20%
Tumor Cell
20%
Tumor Lysis Syndrome
6%
Vitamin Deficiency
6%
Water-Electrolyte Imbalance
6%
